Georgia Keresty joined Takeda Pharmaceuticals in December 2017 and is R&D Chief Operating Officer. She has oversight of the R&D integration for the Shire acquisition, portfolio strategy, management for governance forums such as Portfolio Review Committee (PRC), the Center for Operational Performance (CoOP), the Partnership Office and Takeda’s Regional Development Centers in Zurich, Osaka and Shanghai. Additionally, the COO office will serve as the principal R&D liaison with key enterprise partner functions such as Quality, Procurement, Legal, IT, Intellectual Property (IP), Facilities and Investor Relations and ensure that these key capabilities are optimally integrated into the day-to-day R&D operations.
Prior to joining Takeda, Georgia spent 16 years as a Vice President and executive leader at Johnson & Johnson. Her last role was leading the Pharmaceutical Development and Manufacturing Sciences (PDMS) group within Janssen R&D, overseeing a global team of more than 1,700 scientists, pharmacists and engineers. Prior to J&J, Georgia spent the early part of her career at Novartis and Bristol Myers Squibb where she developed and executed engineering, operations, quality and supply chain strategies.
Georgia is a member of the Board of Directors for Commissioning Agents, Inc., Aspen Technology Inc., and serves on the Board of Trustees for Clarkson University.
Georgia received her BS in chemical engineering from Clarkson University, BS in computer science from Ramapo College of New Jersey, a MS in information systems from Pace University, a MBA from Rutgers University, a PhD in operations management from Rutgers University, and a MPH from the University of Southern California.